PATENT CLAIM ANALYSIS

Application Number: 16400198
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["530", "388220"]

Abstract:
The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to a protein encoded by the Lymphocyte Activation Gene-3 (LAG-3). The invention provides a LAG-3-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides related vectors, compositions, and methods of using the LAG-3-binding agent to treat a disorder or disease that is responsive to LAG-3 inhibition, such as cancer or an infectious disease.

Claim (Index 45):
The LAG-3 binding agent of  claim 43 , wherein the V L  region comprises an amino acid sequence that is identical to SEQ ID NO:88.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 100.0
- Lexical Diversity: 1.78
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15563924', '15567045', '12599430', '11323261', '11929729']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7687679837809089
- 35 USC 102 Novelty (BERT): 0.5987332203593221
- Combined Prediction Score: 0.7517645074387502
- Mean Citation Score: 478.760874
- Max Citation Score: 593.3006
- Similarity Product: 442.7348204452514

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test